NewAmsterdam Pharma
NAMS
NAMS
90 hedge funds and large institutions have $1.38B invested in NewAmsterdam Pharma in 2024 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 30 increasing their positions, 17 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.8% less ownership
Funds ownership: 80.82% → 80.02% (-0.8%)
19% less capital invested
Capital invested by funds: $1.71B → $1.38B (-$323M)
70% less call options, than puts
Call options by funds: $18K | Put options by funds: $61K
Holders
90
Holding in Top 10
5
Calls
$18K
Puts
$61K
Top Buyers
| 1 | +$15.4M | |
| 2 | +$9.29M | |
| 3 | +$7.68M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$7.39M |
| 5 |
Millennium Management
New York
|
+$4.19M |
Top Sellers
| 1 | -$24.2M | |
| 2 | -$9.65M | |
| 3 | -$5.66M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$4.8M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.61M |